Cargando…
VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis
We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a young man diagnosed 13 days after Ad26.COV2.S COVID-19 (Johnson & Johnson/Janssen) vaccination. He presented to us with 5 days of progressive left leg pain, thrombocytopenia, hypofibrinogenemia, and markedly eleva...
Autores principales: | Kennedy, Vanessa E., Wong, Chelsea C., Hong, Jessica M., Peng, Theodore, Brondfield, Sam, Reilly, Linda M., Cornett, Patricia, Leavitt, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483979/ https://www.ncbi.nlm.nih.gov/pubmed/34587255 http://dx.doi.org/10.1182/bloodadvances.2021005388 |
Ejemplares similares
-
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
por: Huynh, Angela, et al.
Publicado: (2022) -
Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
por: Kanack, Adam J., et al.
Publicado: (2022) -
Hemizygous loss of function mutations in CLCN5 causing end-stage kidney disease without Dent disease phenotype
por: Leggatt, Gary, et al.
Publicado: (2022) -
Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022) -
The mysterious death of the beer drinking champ: potential role for hyperacute water loading and acute hyponatremia
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2022)